These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1055538)

  • 1. Effect of dimethyl sulfoxide on the hepatic disposition of chemical carcinogens.
    Levine WG
    Ann N Y Acad Sci; 1975 Jan; 243():185-93. PubMed ID: 1055538
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic intracellular distribution of foreign compounds in relation to their biliary excretion.
    Levine WG; Singer RW
    J Pharmacol Exp Ther; 1972 Nov; 183(2):411-9. PubMed ID: 5083553
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of dimethysulfoxide on the binding of 3-methycholanthrene to rat liver fractions.
    Levine WG
    Res Commun Chem Pathol Pharmacol; 1972 Nov; 4(3):511-8. PubMed ID: 4638589
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin A compounds and analogs as inhibitors of mixed-function oxidases that metabolize carcinogenic polycyclic hydrocarbons and other compounds.
    Hill DL; Shih TW
    Cancer Res; 1974 Mar; 34(3):564-70. PubMed ID: 4812263
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding of benzo(a)pyrene to hepatic cytosolic protein enhances its microsomal oxidation.
    Dixit R; Bickers DR; Mukhtar H
    Biochem Biophys Res Commun; 1982 Feb; 104(3):1093-101. PubMed ID: 6280707
    [No Abstract]   [Full Text] [Related]  

  • 6. Current trends in chemical carcinogenesis.
    Heidelberger C
    Fed Proc; 1973 Dec; 32(12):2154-61. PubMed ID: 4585036
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of different cell constituents on metabolic activation and binding of benzo(a)pyrene to purified and nuclear DNA.
    Guenthner TM; Jernström B; Orrenius S
    Biochem Biophys Res Commun; 1979 Dec; 91(3):842-8. PubMed ID: 526287
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism and biliary excretion of N-2-fluorenylacetamide and N-hydroxy-2-fluorenylacetamide.
    Levine WG
    Life Sci II; 1971 Jul; 10(13):727-35. PubMed ID: 5561052
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of enzyme induction on the metabolism of benzo(a)pyrene and 3'-methyl-4-monomethylaminoazobenzene in the pregnant and fetal rat.
    Welch RM; Gommi B; Alvares AP; Conney AH
    Cancer Res; 1972 May; 32(5):973-8. PubMed ID: 5017744
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of chemiluminescence generation during microsomal metabolism of some carcinogens.
    Emerole GO; Dixon RL
    Cancer Res; 1980 Jun; 40(6):2002-5. PubMed ID: 6768456
    [No Abstract]   [Full Text] [Related]  

  • 11. [Autoradiographic studies on the pattern of distribution and the persistence of radioactive labelled carcinogens in mouse epidermis].
    Oehlert W
    Arch Klin Exp Dermatol; 1966; 227(1):385-9. PubMed ID: 5984787
    [No Abstract]   [Full Text] [Related]  

  • 12. Electron spin resonance study on the metabolism of twelve monohydroxy benzo[alpha]pyrenes in liver microsomes.
    Kimura T; Kodama M; Nagata C
    Gan; 1980 Jun; 71(3):417-8. PubMed ID: 6252086
    [No Abstract]   [Full Text] [Related]  

  • 13. Biliary excretion of 3-methylcholanthrene as controlled by its metabolism.
    Levine WG
    J Pharmacol Exp Ther; 1972 Nov; 183(2):420-6. PubMed ID: 5083554
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic microsomal epoxide hydrase: a sensitive radiometric assay for hydration of arene oxides of carcinogenic aromatic hydrocarbons.
    Jerina DM; Dansette PM
    Mol Pharmacol; 1977 Mar; 13(2):342-51. PubMed ID: 854025
    [No Abstract]   [Full Text] [Related]  

  • 15. Benzo(a)pyrene phenol production by perfused rat liver and its inhibition by ethanol.
    Reinke LA; McManus P; Kauffman FC; Thurman RG
    Cancer Res; 1982 May; 42(5):1681-5. PubMed ID: 6279282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
    Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
    Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of a cytosolic carrier protein fraction in the microsomal metabolism of benzo(a)pyrene in rat liver.
    Hanson-Painton O; Griffin MJ; Tang J
    Cancer Res; 1983 Sep; 43(9):4198-206. PubMed ID: 6307506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The distribution pattern and the length of stay of radioactively labeled carcinogenic hydrocarbons in the pigskin].
    Feit J; Buscher H; Oehlert W
    Beitr Pathol Anat; 1967; 136(1):1-17. PubMed ID: 5621215
    [No Abstract]   [Full Text] [Related]  

  • 19. [The pattern of distribution and uptake of radioactive carcinogens in the skin of the mouse after their local application].
    Oehlert WO; Grimm D
    Z Krebsforsch; 1966; 68(1):14-24. PubMed ID: 4228633
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of microsome-mediated benzo[a]pyrene-metabolism by serum.
    Nemoto N; Takayama S
    Carcinogenesis; 1982; 3(4):359-62. PubMed ID: 6284397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.